Barclays PLC Clovis Oncology, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$1.05 - $2.85 $99,085 - $268,945
94,367 Added 245.7%
132,775 $158,000
Q2 2022

Aug 12, 2022
SELL
$0.63 - $2.96 $23,855 - $112,083
-37,866 Reduced 49.64%
38,408 $69,000
Q1 2022

May 16, 2022
SELL
$1.43 - $3.14 $92,909 - $204,012
-64,972 Reduced 46.0%
76,274 $154,000
Q4 2021

Feb 14, 2022
BUY
$2.7 - $4.76 $248,148 - $437,477
91,907 Added 186.28%
141,246 $383,000
Q3 2021

Nov 09, 2021
BUY
$4.06 - $5.8 $108,324 - $154,749
26,681 Added 117.76%
49,339 $220,000
Q2 2021

Aug 13, 2021
SELL
$5.02 - $7.05 $289,036 - $405,917
-57,577 Reduced 71.76%
22,658 $131,000
Q1 2021

May 13, 2021
BUY
$4.81 - $10.34 $113,968 - $244,995
23,694 Added 41.91%
80,235 $563,000
Q4 2020

Feb 11, 2021
SELL
$4.13 - $6.41 $323,630 - $502,294
-78,361 Reduced 58.09%
56,541 $271,000
Q3 2020

Nov 12, 2020
SELL
$4.82 - $7.72 $1.19 Million - $1.9 Million
-246,204 Reduced 64.6%
134,902 $786,000
Q2 2020

Aug 12, 2020
BUY
$5.69 - $9.69 $1.64 Million - $2.79 Million
287,894 Added 308.86%
381,106 $2.57 Million
Q1 2020

May 13, 2020
SELL
$3.77 - $11.0 $79,682 - $232,496
-21,136 Reduced 18.48%
93,212 $593,000
Q4 2019

Feb 10, 2020
BUY
$3.0 - $16.43 $248,745 - $1.36 Million
82,915 Added 263.78%
114,348 $1.19 Million
Q3 2019

Nov 14, 2019
SELL
$3.93 - $15.35 $689,726 - $2.69 Million
-175,503 Reduced 84.81%
31,433 $124,000
Q2 2019

Aug 14, 2019
BUY
$12.81 - $25.67 $1.72 Million - $3.45 Million
134,312 Added 184.94%
206,936 $3.08 Million
Q1 2019

May 15, 2019
SELL
$17.66 - $30.28 $47,576 - $81,574
-2,694 Reduced 3.58%
72,624 $1.8 Million
Q4 2018

Feb 14, 2019
BUY
$11.63 - $32.67 $2,814 - $7,906
242 Added 0.32%
75,318 $1.35 Million
Q3 2018

Nov 14, 2018
SELL
$29.37 - $49.48 $136,276 - $229,587
-4,640 Reduced 5.82%
75,076 $2.2 Million
Q2 2018

Aug 14, 2018
SELL
$42.06 - $62.4 $726,544 - $1.08 Million
-17,274 Reduced 17.81%
79,716 $3.62 Million
Q1 2018

May 15, 2018
SELL
$50.12 - $67.72 $3.26 Million - $4.41 Million
-65,134 Reduced 40.18%
96,990 $5.12 Million
Q4 2017

Feb 14, 2018
BUY
$57.69 - $84.58 $8.14 Million - $11.9 Million
141,122 Added 671.95%
162,124 $11 Million
Q3 2017

Nov 14, 2017
BUY
$67.17 - $84.81 $1.41 Million - $1.78 Million
21,002
21,002 $1.73 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email